Regeneron to Acquire 23andMe for $256M
Regeneron Pharmaceuticals has agreed to acquire 23andMeās consumer genetics business and assets for $256 million, following 23andMeās Chapter 11 bankruptcy.
About this video
Regeneron Pharmaceuticals has agreed to acquire 23andMeās consumer genetics business and assets for $256 million, following 23andMeās Chapter 11 bankruptcy.
3.6
0 user reviews
Write a Review
User Reviews
0 reviewsBe the first to comment...
Video Information
Views
51
Total views since publication
Duration
0:38
Video length
Published
May 24, 2025
Release date
About the Channel
Related Trending Topics
LIVE TRENDSThis video may be related to current global trending topics. Click any trend to explore more videos about what's hot right now!
THIS VIDEO IS TRENDING!
This video is currently trending in Turkey under the topic 'bursa deprem'.